CTT Pharmaceutical Holdings, Inc. (NASDAQ:CTTH) | WebDisclosure

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Headlines Articles Press releases CTT Pharmaceutical Holdings, Inc.

Home
Companies
CTT Pharmaceutical Holdings, Inc.

PRESS RELEASE

published on 02/25/2025 at 13:15, 11 months 10 days ago

CTT Pharma Gives Update On U.S. and European Patents
CTT Pharmaceutical Holdings, Inc. receives intention to grant additional claims for diabetes drug patent from European Patent Office and plans to utilize micelle technology for enhanced drug delivery. Seeking opportunities for pharmaceutical companies

Drug Delivery European Patent Office Micelle Technology CTT Pharmaceutical Holdings Diabetes Drug Patent
BRIEF

published on 02/12/2025 at 13:20, 11 months 23 days ago

CTT Pharma progresse dans la subvention NSF pour les bandelettes de nicotine

Innovation CTT Pharma Bandelettes De Nicotine Subvention NSF Épidémie De Tabagisme
BRIEF

published on 02/12/2025 at 13:20, 11 months 23 days ago

CTT Pharma Progresses in NSF Grant for Nicotine Strips

Innovation CTT Pharma Nicotine Strips NSF Grant Tobacco Epidemic
PRESS RELEASE

published on 02/12/2025 at 13:15, 11 months 23 days ago

CTT Pharma Gives Update On NSF Grant
CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) advances to the next round of NSF grant program with their patented fast dissolving nicotine strips, aiming to combat the global tobacco epidemic

Public Health Tobacco Epidemic CTT Pharmaceutical Holdings NSF Grant Program Fast Dissolving Nicotine Strips
BRIEF

published on 02/05/2025 at 13:20, 1 year ago

CTT Pharmaceuticals Welcomes Dr. Katherine Cole as Independent Director

Independent Director Biomedical Science CTT Pharmaceuticals Katherine Cole NIH Experience
BRIEF

published on 02/05/2025 at 13:20, 1 year ago

CTT Pharmaceuticals accueille le Dr Katherine Cole au poste de directrice indépendante

Administrateur Indépendant Katherine Cole CTT Pharmaceutique Expérience Du NIH Sciences Biomédicales
PRESS RELEASE

published on 02/05/2025 at 13:15, 1 year ago

CTT Pharma Adds Independent Director With NIH/NSF Experience
CTT Pharmaceuticals Holdings, Inc. welcomes Dr. Katherine Cole, a highly accomplished professional with a Ph.D. in Pathology, as an Independent Director. Dr. Cole's extensive experience in cancer research and academia brings valuable insight to CTT

Bioavailability Drug Delivery CTT Pharmaceuticals Dr. Katherine Cole Ph.D. In Pathology
BRIEF

published on 02/03/2025 at 13:20, 1 year ago

CTT Pharma réduit le nombre d'actions autorisées

Actionnaires Structure Du Capital Réduction Des Parts CTT Pharma Liste De Mise À Niveau OTCQB
BRIEF

published on 02/03/2025 at 13:20, 1 year ago

CTT Pharma Reduces Authorized Share Count

Shareholders Capital Structure Share Reduction CTT Pharma OTCQB Uplist
PRESS RELEASE

published on 02/03/2025 at 13:15, 1 year ago

CTT Pharma Reduces Authorized Share Count
CTT Pharmaceuticals Holdings, Inc. reduces authorized share count by 150 million shares, demonstrating commitment to optimizing capital structure and value to shareholders. Company to uplist to OTCQB

OTCQB Capital Structure CTT Pharmaceuticals Authorized Share Count Micelle Technology

Accesswire

Published on 02/07/2026 at 01:00, 1 day 10 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 11 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 12 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 19 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 21 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 13 hours 59 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 18 hours 24 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 18 hours 39 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 15 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 17 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 16 hours ago

Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 1 day 16 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 18 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 1 day 18 hours ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 2 days 3 hours ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026

View all LES ECHOS COMFI WIRE